Can CBD Stop Alzheimer's? New Study Suggests It May

A groundbreaking study published in Molecular Psychiatry has identified the exact mechanism by which cannabidiol (CBD) activates neuroprotection in Alzheimer's disease, targeting pathways where conventional medications have failed. Researchers discovered that CBD works where other treatments cannot, offering new hope for slowing neurodegeneration in patients with this devastating neurodegenerative condition. This finding represents a significant advance in understanding how cannabinoids interact with brain cells to prevent the cellular damage characteristic of Alzheimer's. For Puerto Rico's aging population, this research opens doors to potential therapeutic applications that could complement existing treatment approaches. While more clinical trials are needed, these results underscore the therapeutic potential of CBD in addressing one of modern medicine's greatest challenges.